Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin Irrigation for Ureteroscopy
NCT06007352Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of gentamicin in urinary tract infection (UTI), sepsis, sponsored by Yale University. Planned start Oct 2024; status: withdrawn.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)sepsis
Beyond the preview
Go deeper on NCT06007352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06007352.